Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Bio-Techne Corporation (TECH) stocks in Canada

Learn how to easily invest in Bio-Techne Corporation stocks.

Bio-Techne Corporation is a biotechnology business based in the US. Bio-Techne Corporation stocks (TECH.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $460.87 – a decrease of 3.55% over the previous week. Bio-Techne Corporation employs 2,600 staff and has a trailing 12-month revenue of around $984.6 million.

How to buy shares in Bio-Techne Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TECH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Bio-Techne Corporation stock price (NASDAQ:TECH)

Use our graph to track the performance of TECH stocks over time.

Bio-Techne Corporation shares at a glance

Information last updated 2022-01-25.
Latest market close$363.81
52-week range$310.11 - $543.50
50-day moving average $462.12
200-day moving average $464.30
Wall St. target price$549.70
PE ratio 83.205
Dividend yield $1.28 (0.35%)
Earnings per share (TTM) $4.34

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Bio-Techne Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Bio-Techne Corporation price performance over time

Historical closes compared with the close of $363.81 from 2022-01-26

1 week (2022-01-21) -0.90%
1 month (2021-12-28) -26.91%
3 months (2021-10-28) -29.39%
6 months (2021-07-28) -23.69%
1 year (2021-01-28) 12.80%
2 years (2020-01-28) 66.56%
3 years (2019-01-28) 121.92%
5 years (2017-01-27) 264.32%

Is Bio-Techne Corporation under- or over-valued?

Valuing Bio-Techne Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bio-Techne Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Bio-Techne Corporation's P/E ratio

Bio-Techne Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 83x. In other words, Bio-Techne Corporation shares trade at around 83x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Bio-Techne Corporation's PEG ratio

Bio-Techne Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7204. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bio-Techne Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Bio-Techne Corporation's EBITDA

Bio-Techne Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $315.3 million.

The EBITDA is a measure of a Bio-Techne Corporation's overall financial performance and is widely used to measure a its profitability.

Bio-Techne Corporation financials

Revenue TTM $984.6 million
Operating margin TTM 26.45%
Gross profit TTM $634.4 million
Return on assets TTM 7.53%
Return on equity TTM 11.35%
Profit margin 17.94%
Book value $41.74
Market capitalisation $14.2 billion

TTM: trailing 12 months

Bio-Techne Corporation share dividends

18%

Dividend payout ratio: 18% of net profits

Recently Bio-Techne Corporation has paid out, on average, around 18% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.35% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Bio-Techne Corporation shareholders could enjoy a 0.35% return on their shares, in the form of dividend payments. In Bio-Techne Corporation's case, that would currently equate to about $1.28 per share.

While Bio-Techne Corporation's payout ratio might seem low, this can signify that Bio-Techne Corporation is investing more in its future growth.

Bio-Techne Corporation's most recent dividend payout was on 25 November 2021. The latest dividend was paid out to all shareholders who bought their shares by 9 November 2021 (the "ex-dividend date").

Have Bio-Techne Corporation's shares ever split?

Bio-Techne Corporation's shares were split on a 2:1 basis on 3 December 2000. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Bio-Techne Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Bio-Techne Corporation shares which in turn could have impacted Bio-Techne Corporation's share price.

Bio-Techne Corporation share price volatility

Over the last 12 months, Bio-Techne Corporation's shares have ranged in value from as little as $310.1123 up to $543.5034. A popular way to gauge a stock's volatility is its "beta".

TECH.US volatility(beta: 1.15)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bio-Techne Corporation's is 1.1465. This would suggest that Bio-Techne Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Bio-Techne Corporation overview

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, and diagnostics and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment provides biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment provides diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and nucleic acid analysis products for use in diagnostic or research applications, as well as instruments and process control products for hematology, blood chemistry, blood gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Novus Biologicals, Tocris Biosciences, ProteinSimple, Advanced Cell Diagnostics, and ExosomeDx brands. Bio-Techne Corporation has a clinical research collaboration with Carterra Inc.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site